510(k) Report

510(k) · Decided

Decided

Coolgard 3000

K060308510(k) TraditionalDecided Apr 26, 200678-day reviewClass II21 CFR 870.5900

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Alsius Corp. · NCX System, Hypothermia, Intravenous, Cooling

Cleared on Apr 26, 2006 after a 78-day review. The FDA summary names its predicate without a number. 3 later devices descend from it.

Decided
Apr 26, 2006
Review
78 days
Class
Class II
Product code
NCX
Recalls
None
Predicates
0

3 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2021: 1 descendant cleared2023: 1 descendant cleared2022: 1 descendant cleared20052010201520202025
  1. This deviceK060308 Coolgard 3000Alsius Corp. · 2006
  2. Descendant · cites it directly · 2 of its ownK213031 Solex 7 Intravascular Heat Exchange Catheter, Cool Line…Zoll Circulation, Inc. · 2021
  3. Descendant · 2 generations on · 1 of its ownK220008 Solex 7 Intravascular Heat Exchange Catheter, Cool Line…Zoll Circulation, Inc. · 2022
  4. Descendant · 2 generations on · 0 of its ownK223746 Solex 7 Intravascular Heat Exchange Catheter, Cool Line…Zoll Circulation, Inc. · 2023

Most influential descendants

Showing 3 of 3 · See all
  • K213031Solex 7 Intravascular Heat Exchange Catheter, Cool Line Intravascular Heat Exchange…Zoll Circulation, Inc. · 2021 · cites it directly2descendants
  • K220008Solex 7 Intravascular Heat Exchange Catheter, Cool Line Intravascular Heat Exchange…Zoll Circulation, Inc. · 2022 · 2 generations on1descendant
  • K223746Solex 7 Intravascular Heat Exchange Catheter, Cool Line Intravascular Heat Exchange…Zoll Circulation, Inc. · 2023 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K060308Coolgard 3000Alsius Corp.2006—
+1K213031Solex 7 Intravascular Heat Exchange Catheter, Cool Line Intravascular Heat…Zoll Circulation, Inc.2021—
+2K220008Solex 7 Intravascular Heat Exchange Catheter, Cool Line Intravascular Heat…Zoll Circulation, Inc.2022—
+2K223746Solex 7 Intravascular Heat Exchange Catheter, Cool Line Intravascular Heat…Zoll Circulation, Inc.2023—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202110
202210
202310
FIG. 1 — Lineage of K060308, 2006–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NCX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NCX device

  1. #1 K213031 Solex 7 Intravascular Heat Exchange Catheter…score 10.9 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Alsius CoolGard and Catheter Thermal Regulation System
Named without a submission number
—

What descends from it? (3)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K213031Solex 7 Intravascular Heat Exchange Catheter, Cool Line Intravascular Heat Exchange…Zoll Circulation, Inc.20212

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K213031 (Zoll Circulation, Inc., 2021) has gone furthest, with 2 descendants of its own.

How does its category compare?

All NCX devices

NCX System, Hypothermia, Intravenous, Cooling: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · NCX

1in 2023

2007: 62008: 32010: 12014: 12015: 12016: 32021: 12022: 12023: 1
2007high 6 (2007) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NCX

204in 2016

2007: 28 days median2008: 129 days median2016: 204 days median
2007high 204 (2016) · low 28 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NCX

28in 2021

2007: 22014: 12021: 28
2007high 28 (2021) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NCX

273in 2025

2007: 42008: 82009: 42010: 92011: 72012: 142013: 312014: 412015: 322016: 3112017: 4502018: 5092019: 4362020: 4152021: 4612022: 5112023: 3732024: 3432025: 273
2007high 511 (2022) · low 4 (2007)2025

MAUDE reports naming product code NCX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200762824
2008312908
20090—04
20101—09
20110—07
20120—014
20130—031
20141—141
20151—032
201632040311
20170—0450
20180—0509
20190—0436
20200—0415
20211—28461
20221—0511
20231—0373
20240—0343
20250—0273
20260—0—

What is it indicated for?

The Alsius CoolGard® 3000 and Cool Line TM Catheter Thermal Regulation System is indicated for use in fever reduction, as an adjunct to other antipyretic therapy, in patients with cerebral infarction and intracerebral hemorrhage who require access to the central venous circulation and who are intubated and sedated.

The COOLGARDTM 3000/Alsius Catheter Thermal Regulation System, using either the lcy Tm or FortiusTM model catheter, is indicated for use:

* in cardiac surgery patients to achieve and or maintain normothermia during surgery and recovery/intensive care, and

* to induce, maintain and reverse mild hypothermia in neurosurgery patients in surgery and recovery/intensive care.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K060308: Coolgard 3000.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K060308

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026